We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

EPIRUS Expands Biosimilar Capabilities Through Acquisition of Bioceros

News   Sep 10, 2015

 
EPIRUS Expands Biosimilar Capabilities Through Acquisition of Bioceros
 
 
 

RELATED ARTICLES

Bacteria Bide Their Time When Antibiotics Attack

News

If an antibiotic doesn’t kill all the bacteria that infects a patient, the surviving bugs may be particularly adept at timing their resurgence.

READ MORE

Antibodies Stabilize Plaque in Arteries

News

An unexpected role for type IgG antibodies has been identified, after a study in mice showed that the antibodies stabilize the plaque that accumulates on the artery walls, reducing the risk of rupture and blood clot.

READ MORE

Microbe Motility Enhanced by Microbiome Metabolites in Colon Chip

News

By leveraging an organ-on-a-chip model and a bioreactor, four human gut metabolites have been identified that can help explain the enhanced sensitivity of the human colon towards enterohemorrhagic E. coli, which is responsible for more than 100,000 infections per year in the USA alone.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE